Landing Page

Engineering cell performance

through custom media design

Engineering cell
performance through
custom media design

We deliver personalised, process-specific cell culture media
to enhance your cell and gene therapy

OUR FOCUS

Enabling efficient manufacturing of advanced therapies with media customised directly for your process

Immune Cell Therapy

We work with CAR-Ts, TILs and CAR-NKs

Developing media for growth, endurance and tumour-killing

Stem Cell Therapy

We work with HSCs, MSCs and iPSCs

Developing media for growth, pluripotency and differentiation

Gene Therapy

We work with HEK293 producing AAV & LVV

Developing media for growth, transfection and viral yield

OUR ADVANTAGES

RAPID DEVELOPMENT

Accelerated timelines to deliver optimised media formulations quickly within weeks, not years.

COMPLEX PHENOTYPES

Optimising media to support advanced cell characteristics and improve functionality.

TAILORED MEDIA DESIGN

Customised solutions aligned with your unique cell-type, target outcome and process needs.

CUSTOM SMALL-BATCHES

Scalable, small-batch media manufacturing tailored for R&D and pre-clinical phases.

AI & ML DRIVEN

Using artificial intelligence, machine learning and advanced data analytics to refine media formulations.

INTEGRATIVE PROCESS

Designed to fit seamlessly within your existing R&D and manufacturing processes.

OUR APPROACH

We provide a comprehensive, end-to-end solution to deliver cell or gene therapy media that is uniquely yours:


We start by designing analyses specifically around your process. After gathering metabolite consumption and cell performance data, we can then pinpoint your cells' current metabolic state.

Process Characterisation


Model-driven Media Optimisation

Next, using AI-powered tools and proprietary computational frameworks, we design optimised media to enhance your cells growth and function.


Quality Control, Validation & Delivery

We then manufacture your media at small-scale media and rigorously QC the product. Finally, we work with you to ensure this media achieves the desired performance and critical quality attributes (CQAs).

Sign up to our early access programme